The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Baxalta; Baxalta; Baxalta; Baxalta; Baxter; Baxter; Baxter; Baxter; Celgene; Celgene; Celgene; Celgene; Incyte; Incyte; Incyte; Incyte; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; QED Therapeutics; QED Therapeutics; QED Therapeutics; QED Therapeutics; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; Merck; Merck; Merck; Merck; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
PANOVA-3: A phase III study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma (LAPC).
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Halozyme; Halozyme; Halozyme; Halozyme
Research Funding - Aduro Biotech; Aduro Biotech; Aduro Biotech; Aduro Biotech; Celgene; Celgene; Celgene; Celgene; FibroGen; FibroGen; FibroGen; FibroGen; Immunomedics; Immunomedics; Immunomedics; Immunomedics; OncoMed; OncoMed; OncoMed; OncoMed
 
Teresa Macarulla
No Relationships to Disclose
 
Philip Agop Philip
Honoraria - Amgen; Amgen; Amgen; Amgen; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Biologics; Biologics; Biologics; Biologics; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Caris MPI; Caris MPI; Caris MPI; Caris MPI; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Lexi Pharma; Lexi Pharma; Lexi Pharma; Lexi Pharma; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Sanofi; Sanofi; Sanofi; Sanofi; SynCoreBio; SynCoreBio; SynCoreBio; SynCoreBio; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck; Merrimack; Merrimack; Merrimack; Merrimack; novartis; novartis; novartis; novartis; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck
Research Funding - Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); halozyme (Inst); halozyme (Inst); halozyme (Inst); halozyme (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); incyte (Inst); incyte (Inst); incyte (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); novartis (Inst); novartis (Inst); novartis (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); tyme (Inst); TYME (Inst); tyme (Inst); TYME (Inst); TYME (Inst); tyme (Inst); tyme (Inst); TYME (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; celgene; celgene; celgene; celgene; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals
 
Carlos Roberto Becerra
Honoraria - Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; HERON; HERON; HERON; HERON; Ipsen; Ipsen; Ipsen; Ipsen; SOBI; SOBI; SOBI; SOBI; Takeda; Takeda; Takeda; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
Tomislav Dragovich
Employment - Taiho Pharmaceutical (I); Taiho Pharmaceutical (I); Taiho Pharmaceutical (I); Taiho Pharmaceutical (I)
Research Funding - ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; Berg Pharma; Berg Pharma; Berg Pharma; Berg Pharma; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Medivir; Medivir; Medivir; Medivir; Rgenix; Rgenix; Rgenix; Rgenix